Abiopharma

🔍 Massad Mark I. (Director)

Company: MIAMI INTERNATIONAL HOLDINGS, INC. (MIAX)

Report Date: 2026-06-15

Detailed Transactions and Holdings:

• Acquired 2,267 shares of Common Stock (Direct)
  Date: 2026-06-15 | Code: A | equity_swap_involved: 0 | shares_owned_after: 5,767.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 4,970 shares of Common Stock (Direct)
  Date: 2026-06-16 | Code: A | equity_swap_involved: 0 | shares_owned_after: 10,737.00 | transaction_form_type: 4 | Footnotes: F2

Footnotes:

• F1: The amount represents restricted stock units ("RSUs") that fully vested on the date of grant. Each RSU represents a right to receive one share of the Issuer's common stock.
• F2: The amount represents RSUs that vest on the last business day immediately preceding the 2027 annual meeting of stockholders, subject to the reporting person's continued service to the Issuer through the vesting date.